Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Change Healthcare Inc

The acquisition will bolster the software and data analytics services that operate behind the scenes to lower overall costs.

UnitedHealth Group to Acquire Change Healthcare in $13 Billion Deal

Shares of Change Healthcare gained as much as 32% to $24 a share on Wednesday after news that UnitedHealth Group is acquiring the health tech firm for roughly $7.8 billion. After the acquisition, Change Healthcare will merge with UnitedHealth Group's health services subsidiary, OptumInsight. Together the companies will connect and simplify core clinical, administrative, and payment processes for the healthcare industry, according to a UnitedHealth statement.

Change Healthcare surges 32% after news of $8 billion acquisition by UnitedHealth (CHNG)

UnitedHealth Group Inc (NYSE:UNH) this morning said it will acquire Change Healthcare (CHNG) for $7.84 billion in cash, or $27.75 per share -- a 41.2% premium to Change stock's closing price on Tuesday.

Billion-Dollar Acquisition Sends UnitedHealth Stock Lower

Health insurer UnitedHealth Group Inc. (NYSE: UNH) announced Wednesday that its OptumInsight division will acquire Change Healthcare Inc.

Why United Healthcare Is Paying $13 Billion for a Medtech Firm

The big health insurer will pay $8 billion in cash and assume roughly $5 billion of debt to acquire Change Healthcare.

UnitedHealth Group Will Buy Health Technology Firm in $13 Billion Deal

Anthem

Cigna

Centene

CVS Health

Humana

Shares of managed-care companies were falling, but analysts say a Democratic win in the Georgia races could mean better funding for health care, and a beefing up of the Affordable Care Act.

Democratic Control of the Senate Is Actually Good for Health Insurance Stocks, Analysts Say

UnitedHealth Group Inc (NYSE: UNH) has announced it is buying Change Healthcare Inc (NASDAQ: CHNG) as part of a $13 billion deal. These are the details.

UnitedHealth Group Inc (UNH) Buying Change Healthcare (CHNG) In Over $13 Billion Deal

UnitedHealth Group Inc. unit Optum has agreed to acquire health care technology company Change Healthcare for $27.75 a share in cash, the companies said in a joint statement Wednesday. "Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone,": said the statement.

UnitedHealth unit Opum to acquire Change Healthcare for $25.75 a share in cash, sending stock up 37% premarket

UnitedHealth Group will buy Change Healthcare for $7.84 billion to merge it with its health IT unit, the company said on Wednesday.

UnitedHealth to buy Change Healthcare for $7.84 billion

EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone.

OptumInsight and Change Healthcare Combine to Advance a More Modern, Information and Technology-Enabled Health Care Platform

Activision Blizzard

ALPS Barron's 400 ETF

Siren Nasdaq NexGen Economy ETF

Roku

Smith & Nephew

Twitter

The rally in 2020 may mean many stocks are not cheap any more, but long-term investors can still find robust stocks to buy in a bull market The post 7 Stocks to Buy for a Continued Run with the Market Bulls appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets

7 Stocks to Buy for a Continued Run with the Market Bulls

Amazon

Costco

Salesforce

Alphabet

Kirkland Lake Gold

NextEra Energy

Teladoc

Visa

Making money is easy when you own stakes in high-quality businesses.

10 Top Stocks That Will Make You Richer in 2021

UnitedHealth Group (UNH) remains well-poised to benefit from growing revenues, robust Medicare business and a solid cash balance.

Here's Why Hold Strategy is Apt For UnitedHealth Group (UNH)

American Well Corporation

The need for touchless treatment, safety, ease, flexibility and efficiency in the current healthcare system makes telehealth a much sought-after option to provide care in the future.

3 Telehealth Stocks to Keep Shaping the Future of Healthcare

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Long-Term Issuer Credit Rating (Long-Term ICR) of “a-” and the Long-Term Issue Credit Ratings (Long-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of UnitedHealth Group. Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICRs of “a+” of the majority of the healt

AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Most Subsidiaries; Upgrades Credit Ratings of Certain Subsidiaries

We believe that UnitedHealth Group stock (NYSE: UNH) has more room for growth in the near term. UNH stock is up 74% off the recent bottom, slightly outperforming the S&P which moved 65% since its March lows, with the resumption of economic activities as lockdowns are gradually lifted.

Should You Buy UnitedHealth Group Stock At $340?

Joint

Molina Healthcare

We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.

3 Health Insurers That Crushed S&P YTD, Set to Rise Further

UnitedHealth Group (UNH) closed at $336.13 in the latest trading session, marking a -0.28% move from the prior day.

UnitedHealth Group (UNH) Stock Moves -0.28%: What You Should Know

MINNETONKA, Minn.--(BUSINESS WIRE)--UnitedHealthcare has introduced enhancements to one of its national well-being programs, providing certain members access for at least six months – at no additional cost – to Apple Fitness+ for studio-style workout classes, powered by Apple Watch. Apple Fitness+ brings studio-style workouts to iPhone, iPad, and Apple TV, intelligently incorporating workout metrics from Apple Watch for a personalized and immersive experience users can complete wherever and whe

UnitedHealthcare Introduces Enhancements for Wearable Device Well-being Program, Including Access to Apple Fitness+ at No Additional Cost

Amgen

Cisco Systems

Goldman Sachs

Home Depot

JPMorgan Chase & Co

McDonald's

Merck

Microsoft

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration."- Dow Jones & Co. 30 Dow stocks represent nine of 11 sectors. Dow tracks utilities as a separate index and omits real estate. Broker top 10 target-estimated net gains ranged 11.05%-18.86% topped by MRK 12/7/20.

December Dogs Of The Dow Run Away

Eli Lilly

The pragmatic study by Lilly (LLY) and UnitedHealth Group (UNH) is set to evaluate bamlanivimab in high-risk symptomatic patients who test positive for COVID-19

Lilly (LLY)/UnitedHealth Launch COVID-19 Study on Bamlanivimab

Eli Lilly & Co. and UnitedHealth Group Inc. said Friday they are joining forces for a study of Lilly's bamlanivimab in high-risk, COVID-19 infected patients. Bamlanivimab is an antibody treatment that recently won U.S. Food and Drug Administration emergency use authorization as a treatment for mild to moderate COVID-19 patients, who are at high risk of getting a severe case of the virus and/or requiring hospitalization.

Eli Lilly and UnitedHealth to study Lilly's antibody treatment bamlanivimab in high-risk COVID patients

INDIANAPOLIS and MINNETONKA, Minn., Dec. 4, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently...

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19

DETROIT--(BUSINESS WIRE)--Amid the ongoing COVID-19 pandemic UnitedHealthcare Community Plan of Michigan has awarded nearly $100,000 in Community Builder Grants to six community organizations aimed at improving access to health care services and addressing social determinants of health. “Through the Community Builder Grant program, we are investing in community partnerships designed to break down barriers to health care services and improve quality of life among underserved populations,” said D

UnitedHealthcare Awards Nearly $100,000 in Community Builder Grants to Six Community Organizations in Michigan

MINNETONKA, Minn.--(BUSINESS WIRE)--UnitedHealth Group announced that Sir Andrew Witty, president of UnitedHealth Group and chief executive officer of Optum, has returned to the company.

News for UnitedHealth Group Stock (UNH)